510(k) Report

510(k) · Cleared

Cleared

Mediostar Next

K111851510(k) SpecialCleared Jul 8, 20119-day reviewClass II21 CFR 878.4810

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Asclepion Laser Technologies GmbH · GEX Powered Laser Surgical Instrument

Cleared on Jul 8, 2011 as substantially equivalent to K053628 (Lumenis, Inc., 2006) and 1 other predicate after a 9-day review. Its family tree reaches back 1 generation to 2005. 33 later devices descend from it.

Decided
Jul 8, 2011
Review
9 days
Class
Class II
Product code
GEX
Recalls
None
Predicates
2

Its longest line of descent runs back 1 generation to K050900 (2005). 2 ancestors in all. 33 later devices descend from it, 1 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 2006: 1 other ancestor2015: 2 descendants cleared2018: 1 descendant cleared2019: 4 descendants cleared2020: 6 descendants cleared2017: 2 descendants cleared2022: 6 descendants cleared2026: 3 descendants cleared2024: 4 descendants cleared2023: 2 descendants cleared2021: 1 descendant cleared2025: 2 descendants clearedK050900 · Mediostar XT · Asclepion Laser Technologies GmbH · 200520052010201520202025
Other ancestors, by generationDescendants, by generation 1 generation back: 1 other ancestor 1 generation forward: 1 descendant2 generations forward: 4 descendants3 generations forward: 11 descendants4 generations forward: 12 descendants5 generations forward: 4 descendants6 generations forward: 1 descendant K050900 · Mediostar XT · Asclepion Laser Technologies GmbH · 20050+5
  1. Root · 1 generation backK050900 Mediostar XTAsclepion Laser Technologies GmbH · 2005
  2. This deviceK111851 Mediostar NextAsclepion Laser Technologies GmbH · 2011
  3. Descendant · cites it directly · 32 of its ownK143519 The MeDioStar NeXT FamilyAsclepion Laser Technologies GmbH · 2015
  4. Descendant · 2 generations on · 13 of its ownK180719 InMode Diolaze SystemInmode MD, Ltd. · 2018
  5. Descendant · 2 generations on · 13 of its ownK152714 Quanta ForteQuanta System Spa · 2015
  6. Descendant · 3 generations on · 8 of its ownK191321 Primelase ExcellenceHigh Technology Products S.L.U · 2019
  7. Descendant · 3 generations on · 5 of its ownK172413 MT ONEM&T S.R.L. · 2017

Showing 5 of 33 descendants. See all descendants

Descendants cleared per year

2015: 22017: 22018: 12019: 42020: 62021: 12022: 62023: 22024: 42025: 22026: 3
2015high 6 (2020) · low 0 (2016)2026

Most influential descendants

Showing 5 of 33 · See all
  • K143519The MeDioStar NeXT FamilyAsclepion Laser Technologies GmbH · 2015 · cites it directly32descendants
  • K180719InMode Diolaze SystemInmode MD, Ltd. · 2018 · 2 generations on13descendants
  • K152714Quanta ForteQuanta System Spa · 2015 · 2 generations on13descendants
  • K191321Primelase ExcellenceHigh Technology Products S.L.U · 2019 · 3 generations on8descendants
  • K172413MT ONEM&T S.R.L. · 2017 · 3 generations on5descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K050900Mediostar XTAsclepion Laser Technologies GmbH2005—
0 (this device)K111851Mediostar NextAsclepion Laser Technologies GmbH2011—
+1K143519The MeDioStar NeXT FamilyAsclepion Laser Technologies GmbH2015—
+2K180719InMode Diolaze SystemInmode MD, Ltd.2018—
+2K152714Quanta ForteQuanta System Spa2015—
+3K191321Primelase ExcellenceHigh Technology Products S.L.U2019—
+3K172413MT ONEM&T S.R.L.2017—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
200610

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201520
201720
201810
201940
202060
202110
202260
202320
202440
202520
202630
FIG. 1 — Lineage of K111851, 2005–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in GEX? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new GEX device

  1. #1 K222064 The Alma Soprano Titaniumscore 38.1 · 24 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K053628Lightsheer Duet Laser System
Summary page 1
…surgery and in dermatology 79-GEX 21 CFR 878.4810 Equivalent Devices: LightSheer Duet K053628 MeDioStar XT K050900 Device Description: The MeDioStar NeXT is a pulsed diode laser emitting…
Lumenis, Inc.2006—
*K050900Mediostar XT
Summary page 1
…79-GEX 21 CFR 878.4810 Equivalent Devices: LightSheer Duet K053628 MeDioStar XT K050900 Device Description: The MeDioStar NeXT is a pulsed diode laser emitting a wavelength of 800 -…
Asclepion Laser Technologies GmbH2005—

Also cleared against K053628: 8 other devices →

What descends from it? (33)

See all 33

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K143519The MeDioStar NeXT FamilyAsclepion Laser Technologies GmbH201532

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • None of the 2 ancestors has a recall.
  • Of its descendants, K143519 (Asclepion Laser Technologies GmbH, 2015) has gone furthest, with 32 descendants of its own.
  • 8 other devices also cite its predicate K053628.

How does its category compare?

All GEX devices

GEX Powered Laser Surgical Instrument: FDA decisions, review times, recalls and adverse event reports over 20 years. 2011, this device’s year, is highlighted.

FDA decisions per year · GEX

83in 2025

2007: 732008: 1072009: 692010: 502011: 412012: 452013: 462014: 612015: 472016: 512017: 672018: 512019: 412020: 522021: 532022: 602023: 522024: 822025: 832026 (partial year): 57
2007high 107 (2008) · low 41 (2011)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · GEX

90in 2025

2007: 79 days median2008: 86 days median2009: 100 days median2010: 96 days median2011: 83 days median2012: 118 days median2013: 144 days median2014: 147 days median2015: 112 days median2016: 114 days median2017: 90 days median2018: 78 days median2019: 88 days median2020: 90 days median2021: 123 days median2022: 152 days median2023: 87 days median2024: 90 days median2025: 90 days median2026 (partial year): 90 days median
2007high 152 (2022) · low 78 (2018)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · GEX

3in 2024

2007: 92008: 22010: 42011: 182012: 52013: 32014: 62016: 12017: 5, 1 Class I2018: 52019: 62020: 12023: 62024: 32026 (partial year): 2
2007high 18 (2011) · low 0 (2009)2026

Class I (1 since 2007) Class II/III not classified

Adverse event reports per year · GEX

2,720in 2025

2007: 3422008: 2322009: 2092010: 1,7112011: 3,0242012: 2,0002013: 2,2362014: 2,0362015: 2,0992016: 2,5852017: 2,9772018: 3,5252019: 2,7092020: 2,1832021: 3,4652022: 2,2882023: 2,3372024: 2,1872025: 2,720
2007high 3,525 (2018) · low 209 (2009)2025

MAUDE reports naming product code GEX, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200773799342
2008107862232
2009691000209
2010509641,711
20114183183,024
20124511852,000
20134614432,236
20146114762,036
20154711202,099
20165111412,585
201767905 (1)2,977
2018517853,525
2019418862,709
2020529012,183
20215312303,465
20226015202,288
2023528762,337
2024829032,187
2025839002,720
202657902—

What is it indicated for?

The MeDioStar NeXT laser system is intended for surgical, aesthetic and cosmetic applications in the medical specialties of general and plastic surgery and dermatology.

The MeDioStar NeXT laser system is intended for the treatment of vascular lesions.

The MeDioStar NeXT laser system is intended for hair removal, permanent hair reduction and the treatment of pigmented lesions.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K111851: Mediostar Next.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K111851

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026